IPO Trending
MONOPHARMASME / NSEListed
Mono Pharmacare

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price₹29.00
Listing Gain+3.57%

Subscription Status

13.47xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB10.89x
Hot Bidding (High Profits)Offered: 5,00,000 sh
Nib8.12x
Popular / Warm DemandOffered: 22,60,000 sh
Retail19.39x
Hot Bidding (High Profits)Offered: 22,64,000 sh
CategoryOfferedAppliedTimes
QIB5,00,00054,44,00010.89x
Nib22,60,0001,83,48,0008.12x
Retail22,64,0004,38,88,00019.39x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB15.241.410.89x
Retail122.896.3419.38x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Mono Pharmacare IPO Subscription Demand

Live subscription status and bidding analysis for Mono Pharmacare (MONOPHARMA) IPO. The issue is subscribed 13.47x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions